Members of George Clinical management team were invited recently to an Investment Dialogue with the Prime Minister of the Netherlands at the Sydney Opera House. The intimate event included key business representatives, the Prime Minister, the Consul-General of the Kingdom of the Netherlands and Australia’s Consul-General to the Netherlands. A select group of companies were […]
Read MoreDr. Maria Ali, CMO, and Meg Jardine, MBBS, Associate Professor at the University of New South Wales and member of the CREDENCE steering committee, discuss the results and implications of the CREDENCE trial. Maria: As a physician, you’ve chosen to focus on research. Why is research like CREDENCE so important for healthcare in general and, […]
Read MoreThe George Institute has been named as one of 13 Australian organizations to receive an Athena SWAN Bronze Institution Award recognizing gender equity and diversity in the workforce. Part of the Science in Australia Gender Equity (SAGE) initiative, this is Australia’s gender equity program for higher education and research organizations in the medical sector. The […]
Read MoreThe George Institute for Global Health’s Co-Founder and Principal Director Dr. Robyn Norton has been nominated as one of The Australian Financial Review’s 2019 top 100 Women of Influence, recognizing her leadership and trailblazing efforts in global health and gender equity. The Women of Influence Award celebrate women leaders who have pushed back against unfairness, […]
Read MoreSYDNEY, October 8, 2019 – George Clinical, a global scientifically-driven clinical research organization (CRO), today announced the promotion of Sean Hart to the new role of Chief Business Officer. Hart, who joined George Clinical through the acquisition of Vector Oncology in 2017, will now lead business development functions globally for the organization. “Sean has demonstrated […]
Read MoreLONDON, August 19, 2019 – George Clinical, a global scientifically-backed clinical research organization (CRO), has expanded its presence in Europe with the opening of a larger and more sophisticated location in the United Kingdom. The office is based in London and compliments the organization’s growing list of global locations throughout the Asia-Pacific region, the United […]
Read MoreIn what could come as a big boost to entrepreneurs working to promote healthcare through innovations across the globe, University of New South Wales—Sydney and The George Institute for Global Health (TGI) have joined forces to launch a program dubbed Health10x designed to accelerate and scale up health focused start-ups. The Health10x program was conceived […]
Read More
George Clinical is pleased to announce that Dr. Bruce Neal has been appointed Executive Director of The George Institute Australia effective September 1. Neal was a founding member of the Institute, together with John Chalmers and Principal Directors Stephen MacMahon and Robyn Norton. Neal has contributed to the growth of the Institute across many areas […]
Read MoreGeorge Clinical welcomes the addition of fixed dose combinations (FDCs) of blood pressure (BP) lowering drugs to the World Health Organization (WHO) Essential Medicines List (EML) in response to an application filed by Resolve to Save Lives (RTSL), an initiative of vital strategies, The George Institute and other partners. Adding FDCs of blood pressure lowering […]
Read MoreA global study of 12 million people has found diabetes increases the risk of heart failure and this increase is greater for women than men. Researchers from The George Institute for Global Health determined that this differential was greater in Type 1 than Type 2 diabetes. Type 1 diabetes is associated with a 47% excess […]
Read More
